The safety of long-term paracetamol use has been called into question in a recent systematic review. However, until large scale well conducted trials of specific patient populations are available, the advice for the prescription of paracetamol should remain unchanged. The balance of risk and benefit to the individual patient has to be considered, and the subsequent efficacy and tolerability reviewed against the alternatives available.